ArticleNeuro-oncology2024

Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort.

Yazmin Odia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.